Form 483

KaryoLogic Inc Form 483, 2025-12-19

FDA issued a Form 483 to KaryoLogic Inc on 2025-12-19 with 9 public-safe observations.

483· Form 483 issuedAnimal Drugs & Feeds9 observations

KaryoLogic Inc · Durham, United States · Issued December 19, 2025

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Dec 2025
21 CFR 211.105(b)

Distinctive ID or code not recorded in batch record

Cited by Marla A Cassidy, William F Lagud

19 Dec 2025
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Marla A Cassidy, William F Lagud

19 Dec 2025
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Marla A Cassidy, William F Lagud

19 Dec 2025
21 CFR 211.194(a)(8)

Second person sign off

Cited by Marla A Cassidy, William F Lagud

19 Dec 2025
21 CFR 211.194(c)

Testing and standardization of standards et. al.

Cited by Marla A Cassidy, William F Lagud

Inspected site

KIKaryoLogic IncDurham, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.105(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.194(c)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere